During the past decade, Allergy Asthma & Clinical Research Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 13 clinical trials were completed, i.e. on average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy Asthma & Clinical Research Center" #1 sponsor was "Meda Pharmaceuticals" with 8 trials, followed by "Sunovion" with 4 trials sponsored, "Optinose US Inc." with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "Regeneron Pharmaceuticals" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy Asthma & Clinical Research Center" #1 collaborator was "Cephalon" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Novella Clinical" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Allergy Asthma & Clinical Research Center" are "Asthma" (12 trials), "Perennial Allergic Rhinitis" (4 trials), "Seasonal Allergic Rhinitis" (4 trials), "Allergic Rhinitis" (3 trials) and "Bilateral Nasal Polyposis" (2 trials). Many other conditions were trialed in "Allergy Asthma & Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Allergy Asthma & Clinical Research Center" are "Drug" (27 trials), "Biological" (8 trials), "Other" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "0.15% azelastine hydrochloride" (2 trials), "OPN-375" (2 trials), "placebo" (2 trials) and "0.1% azelastine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Asthma & Clinical Research Center" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Asthma & Clinical Research Center". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Allergy Asthma & Clinical Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Asthma & Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".